Are You Prepared for the FDA’s Digital Evolution?

Mock FDA Remote Inspection: Remote Regulatory Assessments (RRAs)

The FDA is increasingly utilizing Remote Regulatory Assessments (RRAs) to evaluate compliance without setting foot in your facility. If you aren’t prepared for the nuances of a virtual audit, you are at risk. Unlike large, impersonal firms, we are a small, elite team of former FDA medical device and drug investigators. We bring direct experience in both cGMP and QMSR to your screen. We’ve sat on both sides of the table, making us the most expert, and economical, partner for your compliance journey.

More Info

Be Prepared!

Why Practice a Mock Remote FDA Inspection?

A remote assessment isn’t just a “Zoom call”—it is a rigorous data-driven evaluation. Our mock remote FDA inspection service ensures your team, technology, and documentation are ready for virtual scrutiny.

  • Test Your Technology: Ensure your screen-sharing, document portals, and camera feeds are seamless.
  • Train Your Subject Matter Experts (SMEs): Help your team master the art of answering questions clearly and concisely over video.
  • Audit Your Digital Trails: Identify gaps in electronic records and signatures before the FDA does.

Our Comprehensive Regulatory Expertise

We bridge the gap between complex regulations and operational excellence through:

  • Drug Inspections (CP 7356.002): Specialized oversight for drug manufacturing compliance.
  • QMSR Integration (CP 7382.850): Expert guidance on transitioning to the new Quality Management System Regulation.
  • Combination Products (21 CFR Part 4): Deep technical expertise in dual-compliance for products spanning both drug and device regulations.
  • Critical Process Validation: From ISO 13485 standards to Sterilization Validation and Aseptic Media Fills protocols.

The Advantage: Former FDA Insight

Don’t guess at an investigator’s intent. Let a former FDA investigator with a pharmaceutical and medical device background perform your mock remote FDA inspection. We understand both sides of the table and provide the technical oversight necessary for an informed compliance strategy.

More Info

A Strategic Guide

Mastering the FDA Remote Regulatory Assessment (RRA)

As the FDA continues to evolve its digital oversight, the Remote Regulatory Assessment (RRA) has become a standard tool for evaluating compliance in both the drug and medical device industries. While an RRA is not technically a “Form 482” inspection, the data gathered can lead to a formal inspection, a Form 483, or even a Warning Letter.

Preparing for a virtual evaluation requires a shift in strategy from traditional on-site inspections. Here is how to navigate the process, along with critical tips and pitfalls to avoid.

How to Conduct a Successful RRA Response

The foundation of a successful RRA is digital readiness. Because the investigator cannot physically walk your floors, they will rely entirely on your ability to present clear, narrated, and organized digital evidence.

  1. Establish a “Digital Front Room”: Designate a primary video conferencing platform and a secure document-sharing portal (e.g., SharePoint, Box).
  2. Verify Digital Audit Trails: Ensure that all electronic records and signatures comply with 21 CFR Part 11. During an RRA, investigators often scrutinize metadata and time stamps more closely than during on-site visits.
  3. Optimize Visual Narratives: If the FDA requests a virtual tour, use high-definition cameras with stabilizing equipment. A shaky, low-light cell phone video can create unnecessary suspicion regarding your facility’s state of control.

Critical Tips for Readiness

  • The “Concise SME” Rule: On camera, silences feel longer, and rambling is more obvious. Train your Subject Matter Experts (SMEs) to answer only the question asked. Practice “active listening” to ensure the intent of the investigator’s request is understood before responding.

  • Document Nomenclature: Standardize your filing system. If an investigator asks for a Sterilization Validation or an Aseptic Media Fill report, your team should be able to locate and upload it within minutes. Delays in digital retrieval are often interpreted as a lack of organizational control.

  • The Technology Rehearsal: Conduct a full “Dry Run,” or mock remote FDA inspection with us. Test your microphones, internet stability in the cleanroom, and the clarity of your screen-sharing. A technical glitch during the RRA can derail the flow and increase the investigator’s scrutiny.

Common Pitfalls to Avoid

  • Over-Sharing Data: In a digital environment, it is tempting to dump folders of data into a portal. Only provide exactly what was requested. Excess documentation provides more “surface area” for an investigator to find inconsistencies.

  • Inadequate Back-Room Support: Just because it is remote doesn’t mean you don’t need a “Back Room.” You still need a team to vet documents, scribe the conversation, and prep SMEs before they go “live” on camera.

  • Ignoring the RRA Scope: Whether you are being assessed under CP 7356.002 (Drugs) or CP 7382.850 (QMSR), stay focused on the specific program’s requirements.

By treating the RRA with the same rigor as an on-site inspection, you can demonstrate compliance and maintain a professional relationship with the agency.

More Info